Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients
Secondary hyperparathyroidism (SHPT) remains a treatment dilemma in pediatric dialysis patients. Recent experience with paricalcitol (P), a vitamin D analogue, in adults with SHPT has shown equal efficacy and improved survival compared to traditional treatment with calcitriol (C). We present our exp...
Saved in:
Main Authors: | Wacharee Seeherunvong, Obioma Nwobi, Carolyn L. Abitbol, Jayanthi Chandar, José Strauss, Gastón Zilleruelo |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/23585 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients
by: Kraiwiporn Kiattisunthorn, et al.
Published: (2018) -
Paricalcitol For CKD-MBD Associated With Secondary Hyperparathyroidism: A Case Series Focus On TRAP5b, b-ALP, and DKK-1
by: Budi Suprapti, et al.
Published: (2019) -
Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients
by: Disthabanchong S.
Published: (2023) -
Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.
by: Khan, Behram Ali
Published: (2023) -
Calcitriol Modulates the CD46 Pathway in T Cells
by: Kickler K., et al.
Published: (2019)